Hi,

UC Davis researchers flipped two atoms in LSD’s structure and created JRT which can potentially treat symptoms of schizophrenia. It’s a synthetic analogue that retains LSD’s neuroplastic effects without causing hallucinations. A survey by Trump’s former pollster found that Republicans back states’ rights to legalize marijuana even more than the general voting population. Please legalize it, Mr. President! Jazz Pharm raked in about $972M last year from Epidiolex, its FDA‑approved, pricey CBD med for rare diseases. FYI, since you can’t sell an active drug ingredient over the counter, that exclusivity has basically stalled the wider CBD market and helps explain why the FDA’s been dragging its feet on OTC CBD. I’m sure other big pharma outfits are cooking up similar game plans with cannabis and psychedelics.

Feel free to subscribe to our Cannabis or CBD News Roundups.

Have a brilliant week!
Jessica

04/17/25
Fluent Corp. (CSE: FNT.U) (OTCQB: CNTMF) reports Q4 and full year 2024 results
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) announces proposed reverse stock split and corresponding special meeting of stockholders

04/16/25
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) to announce fiscal Q2 2025 financial results on april 28, 2025

04/15/25
Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) announces proposed private placement offering under the listed issuer financing exemption

04/14/25
Blum Holdings, Inc. (OTCQB: BLMH) provides update on settlement with People’s California, LLC